Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 20 studies | 33% ± 13% | |
type I pneumocyte | 11 studies | 48% ± 15% | |
mesothelial cell | 9 studies | 37% ± 20% | |
endothelial cell | 8 studies | 32% ± 21% | |
adipocyte | 5 studies | 29% ± 9% | |
type II pneumocyte | 5 studies | 33% ± 5% | |
astrocyte | 3 studies | 26% ± 11% | |
retinal pigment epithelial cell | 3 studies | 68% ± 18% | |
myofibroblast cell | 3 studies | 27% ± 10% | |
smooth muscle cell | 3 studies | 26% ± 7% | |
endothelial cell of artery | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 4 studies | 23% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 7234.22 | 571 / 578 | 86% | 40.77 | 993 / 1155 |
thymus | 99% | 5441.93 | 646 / 653 | 85% | 102.96 | 512 / 605 |
prostate | 71% | 2837.54 | 175 / 245 | 63% | 15.03 | 317 / 502 |
breast | 29% | 833.34 | 134 / 459 | 89% | 45.15 | 991 / 1118 |
bladder | 62% | 2553.05 | 13 / 21 | 53% | 16.38 | 269 / 504 |
esophagus | 61% | 2605.31 | 885 / 1445 | 54% | 18.93 | 98 / 183 |
intestine | 49% | 1681.43 | 469 / 966 | 53% | 17.56 | 280 / 527 |
ovary | 49% | 1652.57 | 89 / 180 | 52% | 17.67 | 223 / 430 |
blood vessel | 100% | 48757.58 | 1333 / 1335 | 0% | 0 | 0 / 0 |
kidney | 28% | 920.44 | 25 / 89 | 65% | 27.88 | 588 / 901 |
pancreas | 0% | 9.66 | 1 / 328 | 85% | 48.32 | 151 / 178 |
stomach | 22% | 783.63 | 78 / 359 | 63% | 21.57 | 180 / 286 |
heart | 75% | 4267.85 | 646 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 37% | 965.88 | 96 / 258 | 26% | 4.17 | 59 / 230 |
skin | 32% | 14555.94 | 575 / 1809 | 27% | 13.27 | 127 / 472 |
adipose | 57% | 4228.39 | 690 / 1204 | 0% | 0 | 0 / 0 |
uterus | 15% | 486.29 | 25 / 170 | 35% | 10.99 | 161 / 459 |
tonsil | 0% | 0 | 0 / 0 | 29% | 11.15 | 13 / 45 |
brain | 1% | 42.88 | 36 / 2642 | 18% | 5.59 | 125 / 705 |
liver | 0% | 0 | 0 / 226 | 10% | 1.60 | 40 / 406 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.88 | 2 / 29 |
spleen | 1% | 19.97 | 2 / 241 | 0% | 0 | 0 / 0 |
muscle | 0% | 8.89 | 3 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 2.21 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0001525 | Biological process | angiogenesis |
GO_0035987 | Biological process | endodermal cell differentiation |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0007155 | Biological process | cell adhesion |
GO_0001935 | Biological process | endothelial cell proliferation |
GO_0048593 | Biological process | camera-type eye morphogenesis |
GO_0010811 | Biological process | positive regulation of cell-substrate adhesion |
GO_0005591 | Cellular component | collagen type VIII trimer |
GO_0005615 | Cellular component | extracellular space |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0030020 | Molecular function | extracellular matrix structural constituent conferring tensile strength |
GO_0005515 | Molecular function | protein binding |
Gene name | COL8A1 |
Protein name | Collagen type VIII alpha 1 chain Collagen alpha-1(VIII) chain (Endothelial collagen) [Cleaved into: Vastatin] |
Synonyms | C3orf7 |
Description | FUNCTION: Macromolecular component of the subendothelium. Major component of the Descemet's membrane (basement membrane) of corneal endothelial cells. Also a component of the endothelia of blood vessels. Necessary for migration and proliferation of vascular smooth muscle cells and thus, has a potential role in the maintenance of vessel wall integrity and structure, in particular in atherogenesis. .; FUNCTION: Vastatin, the C-terminal fragment comprising the NC1 domain, inhibits aortic endothelial cell proliferation and causes cell apoptosis. . |
Accessions | A0A087WZI0 ENST00000261037.7 ENST00000452013.5 ENST00000652472.1 P27658 C9JTN9 ENST00000621757.1 ENST00000273342.8 |